Now, let’s step back a bit to understand why. Pneumococcal pneumonia is a type of lung infection caused by bacteria that live in the upper respiratory tract. It typically spreads by coughing or close ...

Children under five years of age, especially those aged two years or under, face a high risk of pneumococcal disease, which is caused by infection of a bacteria -- Streptococcus pneumoniae ...

The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive ...

Multidrug resistance became a serious concern in the treatment of invasive pneumococcal diseases ... is not a common problem in nonmeningeal infection according to the new Clinical and Laboratory ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that Capvaxive be used to prevent invasive disease ...

Pneumococcal disease is an infection caused by a bacteria called Streptococcus pneumoniae. There are about 100 different types (referred to as serotypes) of pneumococcal bacteria, which can affect ...

PNEUMOVAX 23 contains a mixture of inactive parts from 23 of the most common types of pneumococcal bacteria. PNEUMOVAX 23 is a vaccine given to help prevent infections caused by certain types of ...

Advancement to Stage 2 of Infant Study Supported by Review of Stage 1 Safety and Tolerability Data -- -- Company Expects to ...

While they’re not yet declaring it an outbreak, a 53 per cent increase in cases was recorded in 2024 compared to 2023.

Need a break? Play the USA TODAY Daily Crossword Puzzle. Pneumococcal pneumonia is a type of lung infection caused by bacteria that live in the upper respiratory tract. It typically spreads by ...

RAHWAY, N.J., January 31, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Committee for Medicinal Products for Human Use ...